메뉴 건너뛰기




Volumn 201, Issue 4, 2013, Pages 811-824

Update on the management of gastroenteropancreatic neuroendocrine tumors with emphasis on the role of imaging

Author keywords

Gastroenteropancreatic neuroendocrine tumor; Guidelines; Molecular targeted therapy

Indexed keywords

ANGIOPEPTIN; CAPECITABINE; CISPLATIN; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR; ETOPOSIDE; EVEROLIMUS; FLT3 LIGAND; FLUOROURACIL; MAMMALIAN TARGET OF RAPAMYCIN; MICROSPHERE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; OCTREOTIDE; PASIREOTIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PLACEBO; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN KINASE B; RAF PROTEIN; RAS PROTEIN; SOMATOMEDIN C RECEPTOR; STEM CELL FACTOR RECEPTOR; STREPTOZOCIN; SUNITINIB; TEMOZOLOMIDE; UNINDEXED DRUG; VASCULOTROPIN RECEPTOR; YTTRIUM 90;

EID: 84886387609     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.12.10240     Document Type: Review
Times cited : (36)

References (36)
  • 1
    • 85027940811 scopus 로고    scopus 로고
    • Neuroendocrine tumors of the pancreas
    • Milan SA, Yeo CJ. Neuroendocrine tumors of the pancreas. Curr Opin Oncol 2012; 24:46-55
    • (2012) Curr Opin Oncol , vol.24 , pp. 46-55
    • Milan, S.A.1    Yeo, C.J.2
  • 2
    • 77954330417 scopus 로고    scopus 로고
    • Neuroendocrine gastroenteropancreatic tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    • Oberg K, Akerstrom G, Rindi G, Jelic S. Neuroendocrine gastroenteropancreatic tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010; 21(suppl 5):v223-v227
    • (2010) Ann Oncol , vol.21 , Issue.SUPPL. 5
    • Oberg, K.1    Akerstrom, G.2    Rindi, G.3    Jelic, S.4
  • 3
    • 83255171192 scopus 로고    scopus 로고
    • Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)
    • Ramage JK, Ahmed A, Ardill J, et al. Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs). Gut 2012; 61:6-32
    • (2012) Gut , vol.61 , pp. 6-32
    • Ramage, J.K.1    Ahmed, A.2    Ardill, J.3
  • 5
    • 6044252534 scopus 로고    scopus 로고
    • Endocrine tumors of the gut and pancreas tumor biology and classification
    • Rindi G, Kloppel G. Endocrine tumors of the gut and pancreas tumor biology and classification. Neuroendocrinology 2004; 80(suppl 1):12-15
    • (2004) Neuroendocrinology , vol.80 , Issue.SUPPL. 1 , pp. 12-15
    • Rindi, G.1    Kloppel, G.2
  • 6
    • 82155162338 scopus 로고    scopus 로고
    • Neuroendocrine neoplasms of the gastroenteropancreatic system: Pathology and classification
    • Anlauf M. Neuroendocrine neoplasms of the gastroenteropancreatic system: pathology and classification. Horm Metab Res 2011; 43:825-831
    • (2011) Horm Metab Res , vol.43 , pp. 825-831
    • Anlauf, M.1
  • 8
    • 84859417274 scopus 로고    scopus 로고
    • New strategies for advanced neuroendocrine tumors in the era of targeted therapy
    • Dong M, Phan AT, Yao JC. New strategies for advanced neuroendocrine tumors in the era of targeted therapy. Clin Cancer Res 2012; 18:1830-1836
    • (2012) Clin Cancer Res , vol.18 , pp. 1830-1836
    • Dong, M.1    Phan, A.T.2    Yao, J.C.3
  • 9
    • 84857658992 scopus 로고    scopus 로고
    • Neuroendocrine pancreatic tumors: Guidelines for management and update
    • Burns WR, Edil BH. Neuroendocrine pancreatic tumors: guidelines for management and update. Curr Treat Options Oncol 2012; 13:24-34
    • (2012) Curr Treat Options Oncol , vol.13 , pp. 24-34
    • Burns, W.R.1    Edil, B.H.2
  • 11
    • 84862135843 scopus 로고    scopus 로고
    • Neuroendocrine tumors of the digestive tract: Impact of new classifications and new agents on therapeutic approaches
    • Oberg K. Neuroendocrine tumors of the digestive tract: impact of new classifications and new agents on therapeutic approaches. Curr Opin Oncol 2012; 24:433-440
    • (2012) Curr Opin Oncol , vol.24 , pp. 433-440
    • Oberg, K.1
  • 12
    • 69749113601 scopus 로고    scopus 로고
    • ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification
    • Klöppel G, Couvelard A, Perren A, et al. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification. Neuroendocrinology 2009; 90:162-166
    • (2009) Neuroendocrinology , vol.90 , pp. 162-166
    • Klöppel, G.1    Couvelard, A.2    Perren, A.3
  • 13
    • 84863924208 scopus 로고    scopus 로고
    • Lymph node sampling rates and predictors of nodal metastasis in pancreatic neuroendocrine tumor resections: The UCSF experience with 149 patients
    • Parekh JR, Wang SC, Bergsland EK, et al. Lymph node sampling rates and predictors of nodal metastasis in pancreatic neuroendocrine tumor resections: the UCSF experience with 149 patients. Pancreas 2012; 41:840-844
    • (2012) Pancreas , vol.41 , pp. 840-844
    • Parekh, J.R.1    Wang, S.C.2    Bergsland, E.K.3
  • 14
    • 84879504694 scopus 로고    scopus 로고
    • Pancreatic neuroendocrine neoplasms: Diagnosis and management
    • Balachandran A, Tamm EP, Bhosale PR, et al. Pancreatic neuroendocrine neoplasms: diagnosis and management. Abdom Imaging 2013; 38:342-357
    • (2013) Abdom Imaging , vol.38 , pp. 342-357
    • Balachandran, A.1    Tamm, E.P.2    Bhosale, P.R.3
  • 15
    • 84855940639 scopus 로고    scopus 로고
    • The role of somatostatin and dopamine D2 receptors in endocrine tumors
    • Gatto F, Hofland LJ. The role of somatostatin and dopamine D2 receptors in endocrine tumors. Endocr Relat Cancer 2011; 18:R233-R251
    • (2011) Endocr Relat Cancer , vol.18
    • Gatto, F.1    Hofland, L.J.2
  • 16
    • 84862216823 scopus 로고    scopus 로고
    • Nuclear medicine imaging of gastro-entero-pancreatic neuroendocrine tumors: The key role of cellular differentiation and tumor grade-from theory to clinical practice
    • Rust E, Hubele F, Marzano E, et al. Nuclear medicine imaging of gastro-entero-pancreatic neuroendocrine tumors: the key role of cellular differentiation and tumor grade-from theory to clinical practice. Cancer Imaging 2012; 12:173-184
    • (2012) Cancer Imaging , vol.12 , pp. 173-184
    • Rust, E.1    Hubele, F.2    Marzano, E.3
  • 17
    • 77954556448 scopus 로고    scopus 로고
    • Antiproliferative effect of somatostatin analogs in gastroenteropancreatic neuroendocrine tumors
    • Strosberg J, Kvols L. Antiproliferative effect of somatostatin analogs in gastroenteropancreatic neuroendocrine tumors. World J Gastroenterol 2010; 16:2963-2970
    • (2010) World J Gastroenterol , vol.16 , pp. 2963-2970
    • Strosberg, J.1    Kvols, L.2
  • 18
    • 79958182014 scopus 로고    scopus 로고
    • Therapeutic strategies for advanced neuroendocrine carcinomas of jejunum/ ileum and pancreatic origin
    • Auernhammer CJ, Goke B. Therapeutic strategies for advanced neuroendocrine carcinomas of jejunum/ ileum and pancreatic origin. Gut 2011; 60:1009-1021
    • (2011) Gut , vol.60 , pp. 1009-1021
    • Auernhammer, C.J.1    Goke, B.2
  • 19
    • 70350442637 scopus 로고    scopus 로고
    • Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: A report from the PROMID Study Group
    • Rinke A, Muller HH, Schade-Brittinger C, et al. Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group. J Clin Oncol 2009; 27:4656-4663
    • (2009) J Clin Oncol , vol.27 , pp. 4656-4663
    • Rinke, A.1    Muller, H.H.2    Schade-Brittinger, C.3
  • 20
    • 55549090724 scopus 로고    scopus 로고
    • Moertel's land of small tumors
    • Kvols LK, Revisiting C. G. Moertel's land of small tumors. J Clin Oncol 2008; 26:5005-5007
    • (2008) J Clin Oncol , vol.26 , pp. 5005-5007
    • Kvols, L.K.1    Revisiting, C.G.2
  • 21
    • 78650980295 scopus 로고    scopus 로고
    • Surgical management of hepatic neuroendocrine tumor metastasis: Results from an international multi-institutional analysis
    • Mayo SC, de Jong MC, Pulitano C, et al. Surgical management of hepatic neuroendocrine tumor metastasis: results from an international multi-institutional analysis. Ann Surg Oncol 2010; 17:3129-3136
    • (2010) Ann Surg Oncol , vol.17 , pp. 3129-3136
    • Mayo, S.C.1    De Jong, M.C.2    Pulitano, C.3
  • 22
    • 69249165991 scopus 로고    scopus 로고
    • Liver metastases of neuroendocrine carcinomas: Interventional treatment via transarterial embolization, chemoembolization and thermal ablation
    • Vogl TJ, Naguib NN, Zangos S, Eichler K, Hedayati A, Nour-Eldin NE. Liver metastases of neuroendocrine carcinomas: interventional treatment via transarterial embolization, chemoembolization and thermal ablation. Eur J Radiol 2009; 72:517-528
    • (2009) Eur J Radiol , vol.72 , pp. 517-528
    • Vogl, T.J.1    Naguib, N.N.2    Zangos, S.3    Eichler, K.4    Hedayati, A.5    Nour-Eldin, N.E.6
  • 23
    • 77950789991 scopus 로고    scopus 로고
    • Evidence-based imaging of pancreatic malignancies
    • Kinney T. Evidence-based imaging of pancreatic malignancies. Surg Clin North Am 2010; 90:235-249
    • (2010) Surg Clin North Am , vol.90 , pp. 235-249
    • Kinney, T.1
  • 24
    • 84860573042 scopus 로고    scopus 로고
    • Imaging of pancreatic adenocarcinoma: Update on staging/resectability
    • Tamm EP, Balachandran A, Bhosale PR, et al. Imaging of pancreatic adenocarcinoma: update on staging/resectability. Radiol Clin North Am 2012; 50:407-428
    • (2012) Radiol Clin North Am , vol.50 , pp. 407-428
    • Tamm, E.P.1    Balachandran, A.2    Bhosale, P.R.3
  • 25
    • 1442305705 scopus 로고    scopus 로고
    • Carcinoid tumors of the small bowel: A multitechnique imaging approach
    • Horton KM, Kamel I, Hofmann L, Fishman EK. Carcinoid tumors of the small bowel: a multitechnique imaging approach. AJR 2004; 182:559-567
    • (2004) AJR , vol.182 , pp. 559-567
    • Horton, K.M.1    Kamel, I.2    Hofmann, L.3    Fishman, E.K.4
  • 26
    • 84871612736 scopus 로고    scopus 로고
    • Therapeutic monitoring of gastroenteropancreatic neuroendocrine tumors: The challenges ahead
    • Sundin A, Rockall A. Therapeutic monitoring of gastroenteropancreatic neuroendocrine tumors: the challenges ahead. Neuroendocrinology 2012; 96:261-271
    • (2012) Neuroendocrinology , vol.96 , pp. 261-271
    • Sundin, A.1    Rockall, A.2
  • 27
    • 84859118421 scopus 로고    scopus 로고
    • Personalized tumor response assessment in the era of molecular medicine: Cancer-specific and therapy-specific response criteria to complement pitfalls of RECIST
    • Nishino M, Jagannathan JP, Krajewski KM, et al. Personalized tumor response assessment in the era of molecular medicine: cancer-specific and therapy-specific response criteria to complement pitfalls of RECIST. AJR 2012; 198:737-745
    • (2012) AJR , vol.198 , pp. 737-745
    • Nishino, M.1    Jagannathan, J.P.2    Krajewski, K.M.3
  • 28
    • 84883412076 scopus 로고    scopus 로고
    • Liver metastases in the era of molecular targeted therapy: New faces of treatment response
    • Shinagare AB, Jagannathan JP, Krajewski KM, Ramaiya NH. Liver metastases in the era of molecular targeted therapy: new faces of treatment response. AJR 2013; 200:[web]W15-W28
    • (2013) AJR , vol.200
    • Shinagare, A.B.1    Jagannathan, J.P.2    Krajewski, K.M.3    Ramaiya, N.H.4
  • 30
    • 79960321605 scopus 로고    scopus 로고
    • Assessment of the treatment response of HCC
    • Kim KW, Lee JM, Choi BI. Assessment of the treatment response of HCC. Abdom Imaging 2011; 36:300-314
    • (2011) Abdom Imaging , vol.36 , pp. 300-314
    • Kim, K.W.1    Lee, J.M.2    Choi, B.I.3
  • 32
    • 84871285820 scopus 로고    scopus 로고
    • What the emergency radiologist needs to know about treatment-related complications from conventional chemotherapy and newer molecular targeted agents
    • Chikarmane SA, Khurana B, Krajewski KM, et al. What the emergency radiologist needs to know about treatment-related complications from conventional chemotherapy and newer molecular targeted agents. Emerg Radiol 2012; 19:535-546
    • (2012) Emerg Radiol , vol.19 , pp. 535-546
    • Chikarmane, S.A.1    Khurana, B.2    Krajewski, K.M.3
  • 33
    • 84863648475 scopus 로고    scopus 로고
    • Decade of molecular targeted therapy: Abdominal manifestations of drug toxicities-what radiologists should know
    • Howard SA, Krajewski KM, Thornton E, et al. Decade of molecular targeted therapy: abdominal manifestations of drug toxicities-what radiologists should know. AJR 2012; 199:58-64
    • (2012) AJR , vol.199 , pp. 58-64
    • Howard, S.A.1    Krajewski, K.M.2    Thornton, E.3
  • 34
    • 84864954263 scopus 로고    scopus 로고
    • Incidence and management of mTOR inhibitor-associated pneumonitis in patients with metastatic renal cell carcinoma
    • Albiges L, Chamming's F, Duclos B, et al. Incidence and management of mTOR inhibitor-associated pneumonitis in patients with metastatic renal cell carcinoma. Ann Oncol 2012; 23:1943-1953
    • (2012) Ann Oncol , vol.23 , pp. 1943-1953
    • Albiges, L.1    Chamming's, F.2    Duclos, B.3
  • 35
    • 34249085905 scopus 로고    scopus 로고
    • Correlation of CT and PET in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: Proposal of new CT response criteria
    • Choi H, Charnsangavej C, Faria SC, et al. Correlation of CT and PET in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new CT response criteria. J Clin Oncol 2007; 25:1753-1759
    • (2007) J Clin Oncol , vol.25 , pp. 1753-1759
    • Choi, H.1    Charnsangavej, C.2    Faria, S.C.3
  • 36
    • 77349102071 scopus 로고    scopus 로고
    • Modified RECIST (mRECIST) assessment for hepatocellular carcinoma
    • Lencioni R, Llovet JM. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis 2010; 30:52-60
    • (2010) Semin Liver Dis , vol.30 , pp. 52-60
    • Lencioni, R.1    Llovet, J.M.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.